Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma

Journal of Pediatric Surgery

Volumn 40, Issue 6, 2005, Pages 993-998

  Barnett, Sean J ^a   Soto III, Leland J ^a   Sorenson, Brent S ^a   Nelson, Brent W ^a   Leonard, Arnold S ^a   Saltzman, Daniel A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Animal studies; Cancer; Neuroblastoma; Salmonella; Treatment

Indexed keywords

GREEN FLUORESCENT PROTEIN; LIVE VACCINE; RECOMBINANT INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL GENE; CANCER MODEL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ELECTROPORATION; FEEDING; FEMALE; GENE INSERTION; IN VIVO STUDY; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SPECIES INVASION; TUMOR VOLUME;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GREEN FLUORESCENT PROTEINS; IMMUNOTHERAPY; INTERLEUKIN-2; MICE; MICE, INBRED A; NEUROBLASTOMA; RETROPERITONEAL NEOPLASMS; SALMONELLA TYPHIMURIUM; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 20544437792     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.03.015     Document Type: Article

References (33)

1. G.M. Brodeur, and R.P. Castleberry Neuroblastoma P.A. Pizzo D.G. Poplack Principles and practice of pediatric oncology 3rd ed. 1997 Lippincott-Raven Publishers Philadelphia 337
2. R.W. Miller, J.L. Young Jr., and B. Novakovic Childhood cancer Cancer 75 Suppl 1995 395 405
3. K.K. Matthay Neuroblastoma: a clinical challenge and biologic puzzle CA Cancer J Clin 45 1995 179 192
4. A. Garaventa 131 I-metaiodobenzylguanidine therapy for residual neuroblastoma: a mono-institutional experience with 43 patients Br J Cancer 81 1999 1378 1384
5. S. Tepmongkol, and S. Heyman 131 I-MIBG therapy in neuroblastoma: mechanisms, rationale, and current status Med Pediatr Oncol 32 1999 427 431
6. I.Y. Cheung Quantitation of GD2 synthase mRNA by real time reverse transcription-polymerase chain reaction Cancer 94 2002 3024 3028
7. M.F. Ozkaynak Phase I study of chimeric human/murine anti-ganglioside gd2 monoclonal antibody with granulocyte-macrophage-colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation. A Children's Oncology Cancer Group study J Clin Oncol 18 2000 4077 4085
8. K.K. Matthay Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplant, and 13-cis-retinoic acid N Engl J Med 241 1999 1165
9. D.A. Saltzman Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 metastases: a novel anti-tumor agent Cancer Biother Radiopharm 11 2 1996 145
10. D.A. Saltzman Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: a novel anti-tumor agent Cancer Biother Radiopharm 12 1 1997 37
11. D.A. Saltzman Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent J Pediatr Surg 32 2 1997 301
12. B.A. Feltis, and D.A. Saltzman Cyclooxygenase-2 inhibition augments the hepatic anti-tumor effect of oral Salmonella typhimurium in a model of mouse metastatic colon cancer Dis Colon Rectum 45 8 2002 1023 1028
13. L. Soto, B. Sorenson, and B. Nelson Preferential proliferation of attenuated Salmonella typhimurium within neuroblastoma J Pediatr Surg 39 6 2004 937 940
14. R. Curtiss III, and S.M. Kelly Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic Infect Immun 55 1987 3035 3043
15. K. Nakayama, S.M. Kelly, and R. Curtiss III Construction of an ASD+ expression cloning vector stable maintenance and high-level expression of cloned genes in a Salmonella vaccine strain Biotechnology 6 1988 693 697
16. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press
17. E. Katsanis Retroperitoneal inoculation of murine neuroblastoma results in a reliable model for evaluation of the antitumor immune response J Pediatr Surg 29 1994 538 542
18. K.A. Smith Lowest dose interleukin-2 immunotherapy Blood 81 6 1993 1414
19. P.E. Kintzel, and K.A. Calis Recombinant interleukin-2: a biological response modifier Clin Pharm 10 1991 110 128
20. P.M. Anderson, and M.A. Sorenson Effects of route and formulation on clinical pharmacokinetics of interleukin-2 Clin Pharmacokinet 27 1994 19 31
21. R. Whittington, and D. Faulds Interleukin-2: a review of its pharmacologic properties and therapeutic use in patients with cancer Drugs 46 1993 446 514
22. F.M. Marincola Interleukin-2 Biol Ther Cancer Updat 4 1994 1 16
23. S.A. Rosenberg The development of new immunotherapies for the treatment of cancer using interleukin-2 Ann Surg 208 1988 121 135
24. E.A. Grimm, A. Mazumder, and H.Z. Zhang Lymphokine activated killer cell phenomenon J Exp Med 155 1982 1823 1841
25. C.M. Loeffler, J.L. Platt, and P.M. Anderson Antitumor effects of interleukin-2 liposomes and anti-CD3 stimulated T cells against MCA-38 hepatic metastases Cancer Res 51 1991 2127
26. P.M. Anderson, E. Katsanis, and A.S. Leonard Increased local anti-tumor effects of interleukin-2 liposomes in mice with mca-106 sarcoma pulmonary metastases Cancer Res 50 1990 1853 1856
27. P.M. Anderson, D.C. Hanson, and D.E. Hasz Cytokines in liposomes: preliminary studies with IL-1. IL-6, GM-CSF, and Interferon-gamma Cytokine 6 1994 92 101
28. P.M. Anderson, E. Katsanis, and S.F. Sencer Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration J Immunother 12 1992 19 31
29. P.M. Anderson, D. Hasz, and L. Dickrell Interleukin-2 liposomes: increased intravenous potency and less pulmonary toxicity in the rat Drug Dev Res 27 1992 15 31
30. I.Y. Cheung, M.S. Lo Picollo, and N. Collins Quantitation of GD2 synthase mRNA by real time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8 Cancer 94 2002 3024 3028
31. M.F. Ozkaynak, P.M. Sondel, and M.D. Krailo Phase I study of chimeric human/murine anti-ganglioside gd2 monoclonal antibody (ch 14.18) with granulocyte-macrophage-colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Oncology Cancer Group study J Clin Oncol 18 2000 4077 4085
32. L.C. Bowman, M. Grossman, and D. Rill Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma Hum Gene Ther 9 1998 1303 1311
33. J.A. Hank, J. Surfus, and J. Gan Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cytotoxicity against neuroblastoma detected in vitro J Immunother 15 1994 29 37